Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control
Completed
This early-phase trial tested the drug enasidenib in 17 people with low-risk myelodysplastic syndrome or a related leukemia who had anemia and did not have a specific gene mutation. The goal was to see if the drug could safely improve red blood cell counts and reduce the need for…
Phase: PHASE1, PHASE2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC